Nachrichten zur AstraZeneca PLC Aktie

Imfinzi recommended in EU for early gastric cancer

02 February 2026Imfinzi perioperative regimen recommended for approval in the EU byCHMP for patients with early gastric and gastroesophageal cancersRecommendation based on…

AstraZeneca begins trading on NYSE

02 February 2026AstraZeneca begins trading on the New York Stock ExchangeOrdinary shares now trade across the NYSE, LSE and STO under…

AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with Chinas tempting innovation

AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.…

AstraZeneca obesity tie-up with CSPC seen as shrewd move

AstraZeneca PLCs (LSE:AZN, NASDAQ:AZN) licensing deal on Friday signals a plausible effort by the FTSE 100 group to grab a piece…

AstraZeneca strikes $1.2bn obesity drug deal with Chinas CSPC

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is paying $1.2 billion up-front to seal a tie-up with a Chinese pharma giant aimed at expanding…

Chinas CSPC Pharmaceutical inks deal with AstraZeneca for weight loss therapy

CSPC Pharmaceutical Group said on Friday it had entered an agreement with UK drugmaker AstraZeneca for the development of innovative…

Apple AAPL Q1 2026 Earnings Call Transcript

Image source: The Motley Fool.DateThursday, January 29, 2026 at 5 p.m. ETCall participantsChief Executive Officer — Timothy D. CookChief Financial…

AstraZeneca to invest £11bn in China after rowing back on UK expansion

Move comes after Britain’s biggest drugmaker’s dispute with government over drug pricing…

AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities

AstraZeneca has outlined plans to invest $15 billion in | AstraZeneca has outlined plans to invest $15 billion in China through…

AstraZeneca sets out $15 billion China investment during Starmer visit

UK drugmaker AstraZeneca said on Thursday it would invest $15 billion in China through 2030 to expand medicines manufacturing and…

Airbus, AstraZeneca and HSBC executives join UKs Starmer on high-stakes China trip

Executives from Airbus, AstraZeneca and HSBC are joining Prime Minister Keir Starmer on a rare China visit, highlighting the business…

AstraZeneca the top pick among European pharmas

Analysts at Citi see AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) as the top pick among European pharmaceutical firms. and rate the FTSE 100…

HSBC tops $300 billion market value for first time

Shares in HSBC rose as much as 3% to a new record high on Tuesday, briefly lifting the banks market…

Why Astrazeneca (AZN) Outpaced the Stock Market Today

Astrazeneca (AZN) closed at $94.23 in the latest trading session, marking a +1.38% move from the prior day.…

Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note

Astrazeneca (AZN) closed the most recent trading day at $96.34, moving +1.94% from the previous trading session.…

FTSE 100 hits fresh record high as miners rally

The FTSE 100 rose to a fresh record high on Wednesday as strong metals prices lifted miners, and AstraZeneca rose…

Stocks Slide on CPI, Traders Boost June Fed Rate-Cut Odds | The Close 1/13/2026

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after…

Übernahme: AstraZeneca kauft KI-Firma zur Beschleunigung der Medikamentenentwicklung

Die Künstliche Intelligenz soll neue Medikamente schneller finden. Es ist laut AstraZeneca die erste Übernahme eines KI-Unternehmens durch einen großen…

AstraZeneca: Oncology Dominance Justifies New All-Time Highs

…

Walmart To Join Nasdaq 100 on Jan. 20 as AstraZeneca Exits

Walmart Inc. will join the Nasdaq 100 Index, replacing AstraZeneca Plc, Nasdaq Global Indexes said Friday.…

Walmart to replace Astrazeneca on Nasdaq-100

Nasdaq on Friday said U.S. retailer Walmart will replace British drugmaker Astrazeneca in the Nasdaq-100 Index effective on January 20,…

Walmart to replace Astrazeneca on Nasdaq-100 By Reuters

Walmart to replace Astrazeneca on Nasdaq-100…

Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know

Astrazeneca (AZN) concluded the recent trading session at $94.01, signifying a -1.21% move from its prior days close.…

AstraZeneca names Rick Suarez head of US biopharmaceuticals unit

AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the drugmakers…

JNJ vs. AZN: Which Drug Stock Comes Out on Top for Investors?

J&Js diversified pharma and MedTech strength stacks up against AstraZenecas oncology-led growth as investors weigh stability versus faster expansion.…

JP Morgan expects solid AstraZeneca quarter and reassuring outlook

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is set to deliver a solid finish to 2025 when it reports fourth-quarter results next month,…

Total Voting Rights

2 January 2026Transparency DirectiveVoting rights and capitalThe following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

The Zacks Analyst Blog Highlights Berkshire Hathaway, AstraZeneca, Intel, Kingsway Financial and BK Technologies

Berkshire Hathaway headlines new Zacks research reports, with strong insurance performance, cash strength and diversified growth drivers.…

LSEG, Rolls-Royce, AstraZeneca and Rightmove spotlighted as investment bank eyes potential winners for 2026

The festive period is, for some, a time for taking stock of whats happened in the past year - for…

ABBV vs. AZN: Which Pharma Stock is the Better Investment Now?

AbbVie and AstraZeneca both bring blockbuster drugs, deep pipelines and risks, but their growth paths, pressures and priorities now sharply…

AZN, Daiichis Enhertu Gets Breakthrough Tag for Expanded Cancer Use

AstraZenecas Enhertu wins FDA Breakthrough tag for expanded use in breast cancer, while a late-stage study on ceralasertib + Imfinzi…

Jacobio Strikes New Cancer Drug Deal with AstraZeneca

Hong Kong-listed Chinese biotech firm Jacobio Pharma says it hopes to commercialize a new drug that its developing with AstraZeneca.…

AZN, Daiichis Enhertu Gets FDA Nod for First-Line Breast Cancer

AstraZenecas Enhertu wins FDA nod as a first-line treatment for HER2-positive metastatic breast cancer.…

IRW-News: ACCESS Newswire: Eastman, AstraZeneca, Kraft Heinz und P&G mit OMP Supply Chain Awards ausgezeichnet

IRW-PRESS: ACCESS Newswire: Eastman, AstraZeneca, Kraft Heinz und P&G mit OMP Supply Chain Awards ausgezeichnetMIAMI, FLORIDA / ACCESS Newswire /…

AstraZeneca’s Saphnelo approved in EU for self-administration in lupus By Investing.com

AstraZeneca’s Saphnelo approved in EU for self-administration in lupus…

Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts

Astrazeneca (AZN) closed the most recent trading day at $91.56, moving +1.93% from the previous trading session.…

BGH verhandelt Impfschaden-Klage gegen Astrazeneca

KARLSRUHE (dpa-AFX) - Der Bundesgerichtshof (BGH) beschäftigt sich am Montag (11.00 Uhr) mit der Haftung eines…

Exclusive: US FDA launches fresh safety scrutiny of approved RSV therapies for infants

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for…

Leading bank tips AstraZeneca as 2026’s standout UK pharma, with GSK left trailing

JPMorgan has put AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) at the top of its UK healthcare picks for 2026, arguing that the company…

AstraZeneca is top pharma tip for 2026, with GSK left trailing

JPMorgan has put AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) at the top of its UK healthcare picks for 2026, arguing that the company…

ANALYSE-FLASH: JPMorgan hebt Novartis auf Overweight - Ziel 125 Franken

NEW YORK (dpa-AFX Broker) - Die US-Bank JPMorgan hat das Kursziel für Novartis von 95 auf 125 Franken angehoben…

Klage um möglichen Impfschaden - OLG verschiebt Entscheidung

BAMBERG (dpa-AFX) - Im Prozess um die Klage einer Frau aus Oberfranken gegen den Impfstoffhersteller Astrazeneca…

AstraZeneca or Merck: Which Oncology Giant Has the Edge?

AZN and MRK boast major oncology strengths and expanding pipelines amid shifting market dynamics in this pharma matchup.…

Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies

Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations…

Why AstraZeneca Stock Bumped Higher Today

The company is wasting little time figuring out the particulars of a sweeping capital investment program.…

AstraZenecas $2B manufacturing investment in Maryland to create jobs

AstraZeneca is investing $2 billion in manufacturing in Maryland that will support 2,600 jobs, state and company officials announced Friday.…

AstraZeneca to invest $2 billion expanding Maryland manufacturing sites By Investing.com

AstraZeneca to invest $2 billion expanding Maryland manufacturing sites…

AstraZeneca to invest $2 billion as part of US manufacturing push

AstraZeneca said on Friday it will invest $2 billion to expand its manufacturing footprint in Maryland as part of its…

Chutes & Ladders— Former FDA official to lead policy at Hims & Hers; ATA CEO to retire in December

Welcome to this weeks Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the…

Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…